文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

结直肠癌的旁分泌激素假说。

The paracrine hormone hypothesis of colorectal cancer.

作者信息

Pitari G M, Li P, Lin J E, Zuzga D, Gibbons A V, Snook A E, Schulz S, Waldman S A

机构信息

Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

出版信息

Clin Pharmacol Ther. 2007 Oct;82(4):441-7. doi: 10.1038/sj.clpt.6100325. Epub 2007 Aug 8.


DOI:10.1038/sj.clpt.6100325
PMID:17687268
Abstract

Colorectal carcinogenesis originates in the context of dysregulated epithelial cell homeostasis, wherein hyperproliferation, hypodifferentiation, metabolic reprogramming, and mesenchymal remodeling reflect recursive mutually reinforcing mechanisms contributing to progressive genomic instability. Although genotypic and phenotypic elements characterizing the terminal integration of these pathophysiological processes defining cancer are well enumerated, events initiating, coordinating, and sustaining this hierarchical maladaptive systems evolution remain elusive for most tumors. In the intestine, guanylyl cyclase C (GCC) and its paracrine ligands organize and regulate the homeostatic integrity of the crypt-villus axis, forming a hormonal tumor suppressor signaling sequence, whose dysfunction defines the initiation of neoplastic transformation and creates a permissive niche for tumor progression.

摘要

结直肠癌发生于上皮细胞稳态失调的背景下,其中细胞过度增殖、分化不全、代谢重编程和间充质重塑反映了相互递归强化的机制,这些机制导致了渐进性基因组不稳定。尽管明确列举了表征这些定义癌症的病理生理过程最终整合的基因型和表型要素,但对于大多数肿瘤而言,启动、协调和维持这种分级适应性不良系统进化的事件仍然难以捉摸。在肠道中,鸟苷酸环化酶C(GCC)及其旁分泌配体组织并调节隐窝 - 绒毛轴的稳态完整性,形成一种激素肿瘤抑制信号序列,其功能障碍定义了肿瘤转化的起始,并为肿瘤进展创造了有利的微环境。

相似文献

[1]
The paracrine hormone hypothesis of colorectal cancer.

Clin Pharmacol Ther. 2007-10

[2]
Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.

Gastroenterology. 2007-8

[3]
Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.

Cancer Biol Ther. 2010-8-11

[4]
Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.

Cancer Res. 2013-10-1

[5]
Can colorectal cancer be prevented or treated by oral hormone replacement therapy?

Curr Mol Pharmacol. 2009-11

[6]
Overlapping expression of microRNAs in human embryonic colon and colorectal cancer.

Cell Res. 2008-8

[7]
GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?

Drug News Perspect. 2009

[8]
Sex modulates intestinal transformation by the tumor-suppressor GCC.

Clin Transl Sci. 2008-9

[9]
Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.

Clin Pharmacol Ther. 2007-12

[10]
Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.

Semin Cancer Biol. 2018-9-3

引用本文的文献

[1]
Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature.

Front Oncol. 2023-10-20

[2]
LINC00174 Promotes Colon Cancer Progression by Regulating Inflammation and Glycolysis by Targeting the MicroRNA-2467-3p/Enolase 3 Axis.

Mediators Inflamm. 2023

[3]
Emerging drug targets for colon cancer: A preclinical assessment.

Expert Opin Ther Targets. 2022-3

[4]
Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer.

Sci Rep. 2021-8-26

[5]
The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.

Front Oncol. 2018-8-6

[6]
Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders.

Gut. 2018-3-21

[7]
Guanylyl cyclase C signaling axis and colon cancer prevention.

World J Gastroenterol. 2016-9-28

[8]
Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.

Cancer Res. 2016-1-15

[9]
Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.

World J Gastrointest Pharmacol Ther. 2015-11-6

[10]
A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa.

Pharmacol Res Perspect. 2015-3-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索